Print

Galectin Therapeutics Chairman Discusses Details of Fast Track Designation Today at 11 A.M.  
8/16/2013 9:59:33 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ORLANDO, Fla., Aug. 16, 2013 (GLOBE NEWSWIRE) -- RedChip Companies, Inc. ("RedChip"), an international small-cap research, investor relations, and financial media company, today announced that Jim Czirr, executive chairman of Galectin Therapeutics (Nasdaq:GALT), a leading developer of therapeutics that target galectin proteins, will appear in an interview today on RedChip's Internet TV platform at 11:00 a.m. Eastern time. The interview will stream at http://www.redchip.com.

Help employers find you! Check out all the jobs and post your resume.

//-->